World's Best Scientists 2026 revealed!
Pietro Lampertico

Pietro Lampertico

D-Index & Metrics

Medicine

D-Index
80
Citations
32678
World Ranking
16923
National Ranking
677

Pietro Lampertico publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pietro Lampertico sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 906 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pietro Lampertico D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pietro Lampertico sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Pietro Lampertico is a researcher affiliated with the University of Milan in Italy. Their work predominantly centers on the field of Medicine, with a strong focus on Epidemiology and Hepatology. They have contributed extensively to research on infectious diseases, surgery, and oncology, with a particular emphasis on liver-related conditions.

The scientist's research topics mainly cover areas related to hepatology and liver diseases, including:

  • Hepatitis C virus research
  • Liver Disease Diagnosis and Treatment
  • Hepatitis B Virus Studies
  • Liver Disease and Transplantation
  • Hepatitis Viruses Studies and Epidemiology
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Diseases and Immunity

Pietro Lampertico has published frequently in several specialized venues, with a substantial number of publications in:

  • Journal of Hepatology
  • Digestive and Liver Disease
  • Liver International
  • Zeitschrift für Gastroenterologie
  • Alimentary Pharmacology & Therapeutics

Among their recent publications are articles on hepatocellular carcinoma, liver cirrhosis, and hepatitis D virus research. Notable papers include:

  • "Epidemiology and surveillance for hepatocellular carcinoma: New trends," 2020, Journal of Hepatology
  • "High rates of 30-day mortality in patients with cirrhosis and COVID-19," 2020, Journal of Hepatology
  • "aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis," 2020, Journal of Hepatology
  • "Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease," 2021, Gut
  • "A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D," 2023, New England Journal of Medicine

Collaborations are a significant aspect of their research output. Frequent co-authors include:

  • Elisabetta Degasperi
  • Maurizia Rossana Brunetto
  • Roberta D'Ambrosio
  • Heiner Wedemeyer
  • Riccardo Perbellini

Best Publications

  • EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

    Pietro Lampertico;Kosh Agarwal;Thomas Berg;Maria Buti

  • EASL Clinical Practice Guidelines: Management of chronic hepatitis B

    C.P.G.P.P. Marcellin;G. Dusheiko;F. Zoulim;R. Esteban

  • Epidemiology and surveillance for hepatocellular carcinoma: New trends

    Amit G. Singal;Pietro Lampertico;Pierre Nahon

  • Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy

    George V. Papatheodoridis;Henry Lik Yuen Chan;Bettina E. Hansen;Harry L A Janssen;Harry L A Janssen

  • Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

    George V. Papatheodoridis;Pietro Lampertico;Spilios Manolakopoulos;Anna Lok

  • PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

    George Papatheodoridis;George Dalekos;Vana Sypsa;Cihan Yurdaydin

  • Update of the statements on biology and clinical impact of occult hepatitis B virus infection

    Giovanni Raimondo;Stephen Locarnini;Teresa Pollicino;Massimo Levrero

  • Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage

    Claire Dunn;R. Maurizia Brunetto;Gary Reynolds;Theodoros Christophides

  • A global scientific strategy to cure hepatitis B

    Peter A Revill;Francis V Chisari;Joan M Block;Maura Dandri

  • Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients.

    Pietro Lampertico;Mauro Viganò;Elena Manenti;Massimo Iavarone

  • Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.

    Carolina Boni;Diletta Laccabue;Pietro Lampertico;Tiziana Giuberti

  • IL-10–Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus Infection

    Abhishek Das;Gidon Ellis;Celeste Pallant;A. Ross Lopes

  • High rates of 30-day mortality in patients with cirrhosis and COVID-19.

    Massimo Iavarone;Roberta D'Ambrosio;Alessandro Soria;Michela Triolo

  • Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine.

    Pietro Lampertico;Mauro Viganò;Elena Manenti;Massimo Iavarone

  • Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B

    Paola Fisicaro;Valeria Barili;Barbara Montanini;Greta Acerbi

  • Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.

    Eugene Schiff;Cjing Lung Lai;Stephanos Hadziyannis;Peter Nuehaus

  • Clinical outcome of HBeAg‐negative chronic hepatitis B in relation to virological response to lamivudine

    Vito Di Marco;Alfredo Marzano;Pietro Lampertico;Pietro Andreone

  • The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B.

    George V. Papatheodoridis;Ramazan Idilman;George N. Dalekos;Maria Buti

  • Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients

    W. Ray Kim;Thomas Berg;Tarik Asselah;Robert Flisiak

  • Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy.

    Pietro Lampertico;Ersilio Del Ninno;Mauro Viganò;Raffaella Romeo

Frequent Co-Authors

María I. Colombo
María I. Colombo National University of Cuyo
Massimo Colombo
Massimo Colombo Humanitas University
Fabio Facchetti
Fabio Facchetti University of Brescia
George V. Papatheodoridis
George V. Papatheodoridis National and Kapodistrian University of Athens
Maria Buti
Maria Buti Instituto de Salud Carlos III
Harry L.A. Janssen
Harry L.A. Janssen Erasmus University Rotterdam
Massimo Puoti
Massimo Puoti University of Milano-Bicocca
Antonio Craxì
Antonio Craxì University of Palermo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online nursing degrees can be a flexible alternative for those interested in healthcare careers without necessarily attending medical school. For registered nurses looking to advance, rn to bsn no clinical hours programs remove the traditional clinical requirements, making it easier for working professionals to balance studies and responsibilities.

Nurse practitioners or nurses seeking higher credentials can consider advanced options like dnp programs online. These Doctor of Nursing Practice programs are increasingly available in accessible, virtual formats designed for experienced nurses. If speed is your priority, explore the shortest dnp program options which offer accelerated tracks for fast career progression.

For those at the beginning of their nursing journey, lpn online programs provide streamlined pathways to enter practical nursing, often in less time and with greater flexibility compared to traditional routes.

Whether you're just starting out or aiming to take your nursing career to new heights, online pathways offer a range of flexible opportunities that could match your schedule, career goals, and interests.

Best Scientists Citing Pietro Lampertico

Trending Scientists

Recently Published Articles